This book deals with the essential factors in the personalization of treatment for primary breast cancer. These include host issues, lymph node surgery, radiation therapy, and preoperative systemic treatment requiring specialized knowledge, multidisciplinary care experience, techniques, and research. Locoregional treatment in conjunction with systemic treatments is another important factor, with options for local therapy significantly affected by genetic BRCA mutation. Axillary treatment issues have become top priorities in recent primary breast cancer care, and these are highlighted in the book’s presentation of technological advances in lymph node mapping and diagnosis, axillary clearance in patients with nodal metastasis, and the role of axillary surgery. Attention is also given to locoregional treatment after preoperative systemic therapy. Because therapeutic impact differs depending upon biological characteristics such as tumor subtype, local therapy should be based both on tumor biology and on therapeutic response in parallel. Associated translational research and mathematical prediction tools such as nomograms also are introduced. This book provides the essence of primary breast cancer care, particularly its individualization with novel therapeutic concepts and strategies, and will greatly benefit physicians and clinical investigators in breast cancer institutions.
This book provides detailed information on the etiology, pathogenesis, diagnosis, prognosis, and treatment strategies for breast cancer.
... bolstering their identity as a worthwhile, active and valuable person as a way of coping with what was often a shocking discovery of cancer which encroached on their future (Chattoo and Ahmad 2003; Hubbard et al.
Tools such as sidebars, key concept summaries, a glossary, and acronym and abbreviation definitions make this book highly accessible to researchers from several fields associated with cancer genomics.
This book presents the latest advances in precision medicine in some of the most common cancer types, including hematological, lung and breast malignancies.
Towards precision medicine for pain: diagnostic biomarkers and repurposed drugs. ... Torrado JC, Gomez J, Montoro G. Emotional self-regulation of individuals with autism spectrum disorders: smartwatches for monitoring and interaction.
Focusing on cancer of the breasts, ovaries, uterus, cervix, vagina and vulva - provides readers with that critical information to help them manage, cope, and recover through a concise, easy-to-read style and format.
“Realizing the Promise of Personalized Medicine.” Harvard Business Review 85 (10): 10817. https://hbr.org /2007/10/realizing-the-promise-of-personalized-medicine. CIGNA. 2017. “Medical Coverage Policy: Genetic Testing for Hereditary and ...
This book covers almost all fields of cancer genetics and genomics for personalized medicine. Targeted therapy, or precision medicine, or personalized medicine is becoming a standard treatment for many diseases, including cancer.
This book provides a unique perspective on the biomedical and societal implications of personalized medicine and how it helps to mitigate he healthcare crisis and rein in ever-growing expenditure.
Liu in DPC4 Hua to 110. Sos ML, Koker M, Weir BA, et al. ... The t(X;1)(p11.2;q21.2) translocationin papillaryrenalcell carcinomafuses anovelgene PRCCtotheTFE3 transcription factor gene.HumMolGenet. 1996;5(9):13331338. 125.